CA2088384C - Defibrillator waveform generator for generating waveform of long duration - Google Patents
Defibrillator waveform generator for generating waveform of long durationInfo
- Publication number
- CA2088384C CA2088384C CA002088384A CA2088384A CA2088384C CA 2088384 C CA2088384 C CA 2088384C CA 002088384 A CA002088384 A CA 002088384A CA 2088384 A CA2088384 A CA 2088384A CA 2088384 C CA2088384 C CA 2088384C
- Authority
- CA
- Canada
- Prior art keywords
- waveform
- duration
- capacitor
- defibrillation
- electrode structure
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3956—Implantable devices for applying electric shocks to the heart, e.g. for cardioversion
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3906—Heart defibrillators characterised by the form of the shockwave
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
- A61N1/39—Heart defibrillators
- A61N1/3906—Heart defibrillators characterised by the form of the shockwave
- A61N1/3912—Output circuitry therefor, e.g. switches
Abstract
An implantabledefibrillator/cardioverter which generates a biphasic waveform having a duration of at least 15-80 msec and a small "tilt" between the leading edge and trailing edge voltages of each phase. In one embodiment, two capacitors are connected in parallel to create an effectively large capacitance to generate a slowly decaying waveform. In another embodiment, a high capacitance bipolar capacitor is used, which capacitance is at least 200 microFarads.
Description
.
DEFTRRTT.T.~TOR WAVEFORM GT'NT'T~TOR
FOR GT~'NT~'T~TING WAVEFORM OF LONG DURATION
BACKGROUND OF THE INVENTION
The present invention relates to cardiac defibrillation, and more particularly to a defibrillation system including a pulse generator which generates a long duration defibrillation waveform.
When used hereinafter, the term "defibrillation" is meant to include high energy defibrillation and lower energy cardioversion.
Present defibrillation devices generate and deliver a truncated exponential waveform with a duration less than 12 msec, or some variation thereof. According to conventional wisdom, the use of defibrillation waveforms with durations 15-20 msec or longer would be counter-indicated for defibrillation. In particular, it has been the assumption by experts in the field that the strength-duration relationship of a biphasic waveform are the same as for a monophasic waveform. That is, it is the general consensus that increasing waveform duration prohibitively increases the necessary energy requirements.
:"
_ In the last five years, there have been several reports of human and animal studies showing that some biphasic waveforms are more efficacious than monophasic waveforms. See Jones et al., "Increasing Fibrillation Duration Enhances Relative Asymmetric Biphasic Versus Monophasic Defibrillator Waveform Efficacy", Circulation and Respiration, 376-384, Vol. 67 (1990); Bardy et al, "A Prospective Randomized Evaluation of Bipolar Versus Monopolar Waveform Pulses on Defibrillation Efficacy in Humans", Journal of the American College of Cardiology, 728-733, Vol. 14 (1989); and Winkle et al., "Improved Low Energy Defibrillation Efficacy in Man With the Use of a Biphasic Truncated Exponential Waveform", American Heart Journal, 122-127, Vol. 117 (1989). These articles describe a ratio of energy requirements of a biphasic waveform as compared to the monophasic waveform that is less than 1Ø None of these articles indicate that ratio may be dependent on waveform duration.
The present generation of defibrillators have, to a large extent, been designed using strength-duration data determined with monophasic waveforms. When monophasic truncated exponential waveforms are used, defibrillation waveforms with long pulse durations (>10 msec) have no advantages over shorter duration waveforms.
Therefore, manufacturers of implantable defibrillator devices have used output capacitors with a capacitance of 60 to 150 microFarads and waveform durations less than 15 msec, and typically less than 10 msec. Waveform durations have been maintained - - -bstantially the same as manufacturers have changed their defibrillator designs to produce biphasic defibrillation shocks.
Recent patents further demonstrate that state-of-the-art defibrillation waveforms have durations shorter than 15 msec. See, for example, U.S. Patent No. 4,548,203 to Tacker, Jr. et al., 4,953,551 to Mehra et al., and 4,821,723 to Baker et al.
It is known that the pulse duration has a major impact on the strength requirements for stimulating tissue. Since most theories of defibrillation involve stimulation of refractory tissue, one would expect the strength-duration relationship for defibrillation to be at least qualitatively similar to that of pacing. This has been born out by studies by Wassale et al. and Konig et al. and described in their respective articles "Bipolar Catheter Defibrillation in Dogs Using Trapezoidal Waveforms of Various Tilts", Journal of Electrocardiology, 359-366, Vol. 13 (1980), hereinafter "Wassale et al."; and "Amplitude-Duration Relationship for Direct Ventricular Defibrillation with Rectangular Current Pulses", Medical Biological Enqineerinq, 388-395, Vol. 13 (1975), hereinafter "Konig et al.". The overall shape of the strength-duration curves for defibrillation with both monophasic truncated exponential and rectangular waveforms are similar to those determined for pacing. However, the pulse durations that minimize energy delivery requirements are lower for pacing (0.5 msec) as described by Irnich in the article "The Chronaxie Time and Its Practical Importance", PACE, 292-301, Vol. 3 (1980), 208838~
-einafter "Irnich", than for defibrillation (4 msec) as described -by Wassale et al.
Defibrillation with monophasic waveforms appears to follow a hyperbolic strength-duration relationship, as does pacing.
Defibrillation strength requirements have been measured for rectangular waveforms of different durations (1, 2, 5, 10, 20, 30 and 40 msec). See Konig et al. A good fit was found between their current amplitude data and a hyperbolic strength-duration curve with a chronaxie (a duration that gives minimum energy) at about 4 msec. In the aforementioned article by Wassale et al., strength-duration curves for monophasic truncated exponential waveforms were determined for several different tilts. Current requirements for these trapezoidal waveforms also increased as shock duration decreased, but shock energy was minimized at 2 to 4 msec, depending on the tilt. Both studies show a strength-duration relationship for defibrillation that is similar to that seen in pacing.
However, it was found by Irnich that the chronaxie for pacing with rectangular waveforms is about 0.5 msec, while the chronaxie for defibrillation with monophasic waveforms is about 4 msec.
In an article by Chapman et al. entitled "Strength-Duration Curves of Fixed Pulse Width Variable Tilt Truncated Exponential Waveforms for Nonthoracotomy Internal Defibrillation in Dogs", PACE, 1045-1050, Vol. 11 (1988). The curve of delivered energy requirements versus pulse width for delivered energy is described for single-capacitor monophasic wa~eforms (exponential with fixed time constants). Energy requirements increased 2088~84 ~otonically by only 50% as duration was increased from 2.5 to 15 msec, then increased dramatically for pulses of 20 msec durations.
Energy requirements for the 20 msec pulse were 1.5 times that of the energy required for 15 msec pulses.
Feeser et al., in their article entitled "Strength-Duration and Probability of Success Curves for Defibrillation With Biphasic Waveforms", Circulation, 2128-2141, Vol. 82 (1990), showed that for at least some biphasic waveforms, extending waveform durations to more than 15 msec dramatically increases energy requirements. However, unlike our experiments described below, tilt was not held constant in any of their experiments. In the study described by Feeser et al., trailing edges for long waveforms were sometimes very low. MacDaniel et al., in their article entitled "Optimal Biphasic Duration for Canine Defibrillation with a 'Single Capacitor' Waveform and a Non-Thoracotomy Electrode System", Annual Conference of IEEE EMBS, 1990, Volume 12, pages 636-637, showed that, for monophasic pulses of long duration, low trailing voltages are disadvantageous.
It has previously been shown that for fixed-duration shocks, the effectiveness of the truncated biphasic waveforms is critically dependent on the exact shape of the waveform. MacDaniel et al. and Feeser et al. have shown that for single capacitor waveforms, defibrillation shock efficacy varies as the ratio of the durations of the first and second phases is changed. Biphasic waveforms with first or second phases of short duration are actually less efficacious than monophasic pulses.
The strength-duration curves we found for the type of biphasic waveforms used are very different from those previously determined for truncated monophasic waveforms. The strength-duration relationship for energy requirements with biphasic truncated exponential waveforms were relatively flat and may greatly improve implantable defibrillator designs. Specifically, we discovered that defibrillation with long biphasic defibrillation pulses (20 msec) requires significantly lower peak voltages, with almost no increase in energy requirements.
Animal studies involving the present invention studied the effect of waveform duration on defibrillation efficacy of a biphasic truncated exponential waveform in six pigs. In each pig, defibrillation success curves were determined for waveform durations of 3, 5, 7, 10, 15 and 30 msec. The waveform shape chosen was of the "single capacitor" type with the trailing edge of the first pulse equal in magnitude to the leading edge of the second. The first pulse terminated at 40%, and the second pulse at 20% of the initial voltage of the first pulse, with the time constants of each phase being equal.
The effect of waveform duration on defibrillation efficacy of a monophasic truncated exponential waveform was determined in an additional six pigs. Waveform durations were the same as with the biphasic waveform, except the longest duration tested was 24 msec rather than 30 msec. The monophasic waveform terminated at 40% of the initial voltage.
All shocking electrodes were placed by fluoroscopy. One llF 3.4 cm long coil was positioned in the right ventricle and another coil of the same dimension was located in the high right atrium. A subcutaneous wire array electrode (100 cm2) was positioned such that the image of the right ventricular shocking coil and the subcutaneous electrode coincided in a lateral view.
Thoracic X-ray films were made to verify correct placement of both shocking catheters and the subcutaneous electrode.
Fibrillation was allowed to run for 15 seconds after induction with a 9 volt DC signal between an endocardial sensing lead and an indifferent electrode. Then defibrillation was attempted with a defibrillator designed for research using a shock of the selected waveform duration. Rescue monophasic transthoracic defibrillation shocks were given with an external defibrillator (about 100 J) through an electrode pad on the right thorax and the subcutaneous electrode on the left. Only the initial shock of each fibrillation episode was used to evaluate defibrillation efficacy.
The energy requirements for defibrillation were measured for the six waveform durations with the shocks being delivered according to an interleaved up/down protocol (described below). A total of 15 shocks were delivered by this protocol for each of the six durations (a total of 90 shocks). Data from these shocks were used to determine probability-of-success curves for each waveform duration.
208~384 TABLE I
Peak Current Am~litudes of First Shocks For Waveforms of Indicated Duration 8iphasic Monophasic 5Duration Peak I (Amp) Duration Peak I (AmP) 3 22.5 3 22.5 13.3 5 12.0 7 10.0 7 12.0 7.8 10 12.0 7.0 15 12.0 6.3 24 12.0 Table I above shows the peak delivered current for the initial shock given for each of the six waveform durations. It should be noted that the current levels for first shocks were different for the monophasic and biphasic waveforms. For all succeeding shocks, the peak current and success of the immediately preceding shock with that waveform duration determined the peak current selected. If the prior shock at that waveform duration failed, then the peak current was increased by one step; for a successful shock, the peak current was decreased by one step.
Initial current step sizes were 20%; at the first reversal, the step size was decreased to 10%.
The interleaving protocol was carried out as follows.
The six durations were arranged in random order, then the first test shocks for each duration were delivered in that random order.
The order was again randomized, and the second test shock for each duration were delivered according to the new order. That process was continued with 15 separate randomizations of order used, one for each of the 15 shoc~s delivered for each shock duration. This methodology ensured that, for example, the tenth shock given at one 208838~
~ ation always preceded the eleventh shock given at another duration.
Pulse width and initial current were selected by the protocol described above. These values, plus the measured energy and voltage were recorded for each shock. Two minutes separated each fibrillation-defibrillation episode, unless more time was required for the animal to return to basal conditions as indicated by surface or endocardial ECG's, or blood pressure measurements.
For each pulse duration, two parameter probability-of-success curves (mid-point and width) were determined for delivered energy, peak voltage and current. To produce the sigmoid defibrillation success curves, modified error functions were fitted to the data of conversion success or failure for each measured value using the maximum likelihood method. For each pulse duration, the energies, voltages and currents at which the percent probabilities for defibrillation success equaled 50~ (E50, V50 and I50) and 80% (E80, V~0 and I80) were determined from the success curves.
As shown in Figure 1, for the biphasic waveform, it was found that shock duration had no statistically significant effect on energy requirements over the range of 3 to 15 msec. Energy requirements were increased about 25% for shock durations of 30 msec. For the monophasic waveform as shown in Figure 1, defibrillation energy requirements increased monotonically as shock durations were increased from 3 to 24 msec. The E50 for shocks 3 20~83~4 _, msec long was 11.6+3.1 joules compared to 36.8+9.7 joules for shocks 24 msec long.
For the biphasic waveforms, it was found that current and voltage requirements declined monotonically with increases in waveform duration as shown in Figure 2.
Peak current and voltage requirements were 2.5 times higher for waveform durations of 3 msec than for durations of 30 msec. For the monophasic waveforms, current and voltage requirements declined significantly as shock durations were increased from 3 to 10 msec as shown in Figure 3. There was no significant further decreases as the durations were set at 15 and 24 msec, respectively.
It is therefore an object of the present invention to provide a novel system for generating a defibrillation waveform including a defibrillator and an electrode structure.
SUMMARY OF THE INVENTION
According to one aspect of the present invention there is provided a system for generating a defibrillation waveform including a defibrillator and an electrode structure, the system comprislng:
a single capacitor having a capacitance of at least 200 microFarads;
means for charging said capacitor to a maximum voltage of less than 400 volts;
A
switch means for connecting said capacitor to said electrode structure; and switch control means for controlling said switch means to connect said capacitor to said electrode structure for discharge via said electrode structure in a first polarity for a first phase of a biphasic waveform, and to connect said capacitor to said electrode structure in a polarity opposite said first polarity for a second phase of said biphasic waveform:
the first phase having duration equal to or greater than said second phase, the total duration of the first and second phases being at least 15 milliseconds, a trailing edge voltage of said first phase being greater than fifty percent of a leading edge voltage of the first phase and the biphasic waveform having a fixed tilt so as to produce a fixed low tilt biphasic waveform.
Preferably, a single large value, low leakage bipolar capacitor is used. It is also preferred that the defibrillation shock waveform has an overall duration of 15 msec to 80 msec. From our animal experiments, we expect to substantially reduce current and voltage requirements with such waveforms in external and implantable defibrillation systems.
There are several advantages to a defibrillation waveform requiring lower peak voltages.
First, tissue stunning, heart block and heart dysfunction are minimized. Second, the pulse generator output circuitry may be simplified and have greater reliability.
.~
20~3~4 BRIEF DESCRIPTION OF THE DRAWINGS
The above and other objects and advantages will become more readily apparent when reference is made to the following description taken in conjunction with the accompanying drawings in which:
Figure 1 is a graph illustrating energy versus duration relationships for monophasic and biphasic waveforms determined from animal studies.
Figure 2 is a graph illustrating voltage and current versus duration relationships for biphasic waveforms determined from animal studies.
Figure 3 is a graph illustrating voltage and current versus duration relationships for monophasic waveforms determined from animal studies.
Figure 4 is a schematic diagram illustrating the implantable defibrillation system according to a first embodiment of the present invention.
Figure 5 is a diagram of a biphasic waveform generated by the pulse generator of the implantable defibrillation/cardioversion system according to the present invention.
Figure 6 is a schematic diagram illustrating the implantable defibrillation system according to a second embodiment of the present invention.
.
' 12a DETAILED DESCRIPTION OF THE DRAWINGS
Figure 1 illustrates the strength-duration relationships for delivered energy of a constant-tilt biphasic waveform and of a constant-tilt monophasic truncated exponential waveform. The data from this graph were obtained from two series of pig experiments, the details of which are described above. Energy requirements were s~nificantly lower for the biphasic waveform at all durations tested above 5 msec. It is quite evident from this figure that the relative benefit of the biphasic waveform is very dependent on waveform duration. For durations of 3 or 5 msec, the energy advantage for the biphasic waveform is small. However, for the durations used according to the present invention, the biphasic energy requirements are several-fold lower than the monophasic waveform. It should also be noted that the strength-duration curve for energy of the biphasic waveform is quite flat over waveform durations of 3 to 30 msec.
Figures 2 and 3 illustrate the strength-duration relationships for peak voltage and current requirements for constant-tilt biphasic and monophasic waveforms, respectively. The data from these graphs were obtained from two series of pig experiments, the details of which are described above. Figure 2 shows that for the constant-tilt biphasic waveform, peak voltage and current requirements decrease monotonically with increases in duration for pulse durations of 3 to 30 msec. A comparison of Figure 1 and 2 shows that peak voltage and current can be decreased substantially, with almost no penalty in increased energy requirements, if a biphasic waveform with long duration (greater than 15 msec) is used. In contrast, for the monophasic waveform, no significant changes in peak voltage and current requirements were observed as waveform duration was increased from 10 to 24 msec (Figure 3).
208838~
- Figure 4 illustrates the defibrillation system according to the first embodiment, which is generally shown at 10. The system 10 includes sensing electrodes 12 and circuitry for amplifying and analyzing the cardiac rhythm, in the form of an ECG
amplifier 14 and a cardiac analyzer 16. The cardiac analyzer 16 determines when the heart is in a condition requiring a defibrillation (or cardioversion) shock and issues a control signal, causing the shock to be delivered to the heart via electrodes 18 and 20. The system 10 (as well as system 10' to be described hereinafter) represents an implantable or external defibrillation system. In an implantable system, electrodes 18 and 20 may be implanted on or about the heart, one may be subcutaneous, and each may comprise one or more electrode, though only one is shown for each. In the case of an external defibrillator, the circuitry may be disposed external to the body of a patient but connect with implantable electrodes. Alternatively, the external unit may connect with at least two cutaneous electrodes placed on the body.
The thrust of the present invention lies in the pulse generator circuitry, which is generally shown at 22. The pulse generator circuitry includes capacitors Cl and C2 connected in parallel. The capacitors Cl and C2 are charged by the voltage supply Vc via a DC-DC converter 21, and are connected to the electrodes 18 and 20 via lead lines 24 and 26. A plurality of switches S1-S4 are provided between t~e capacitors Cl and C2 and the lead lines 24 and 26. Preferably, capacitors Cl and C2 are 250 Il roFarads each, but may be in the range of 100-800 microFarads.
-The overall capacitance therefore is the sum of the capacitance of capacitors Cl and C2, which in the preferred embodiment is 200 to 1600 microFarads, but at least 200 microFarads or greater.
A switch controller 30 is provided to control the switches S1-S5, for controlling the charge and discharge of the capacitors Cl and C2. In general, the switch controller 30 controls the switches so that a biphasic waveform is generated from the discharge of the capacitors Cl and C2.
With reference to Figures 4 and 5, the method by which the biphasic waveform 40 is generated will be described. The capacitors Cl and C2 are charged via the voltage supply Vc, by closing the switch S5. This may be controlled by the switch controller 30, or the cardiac analyzer 16. Once charged, the switch controller generates phase 1 of the waveform by closing switches S1 and S4, and opening switches S2 and S3. This connects the capacitors Cl and C2 with positive polarity to lead lines 24 and 26. The discharge waveform for phase 1 will slowly decay from a leading edge voltage VLl to a trailing edge voltage VTl. The decay from VLl to VTl will be slow because the time constant for the circuit will be large, due to the sum of the capacitances of capacitors C1 and C2.
For the second phase of the waveform, the switch controller 30 opens switches Sl and S4 and closes switches S2 and S3, thereby connecting capacitors Cl and C2 to lead lines 24 and 26 with a polarity opposite to that of phase 1. Similar to phase 1, 208~384 ~_ discharge waveform for phase 2 decays at a rather slow rate from the leading edge voltage VL2 to the trailing edge voltage VT2.
The magnitude of the leading edge voltage of phase 2, VL2, is equal to the magnitude of the trailing edge voltage VT1 of phase 1.
Preferably, the duration of the waveform shown in Figure 5 is 20-40 msec, with the first phase consuming 60 percent of the total duration. In addition, the trailing edge voltage VT1 of the first phase is preferably larger than fifty percent of the leading edge voltage VL1, giving a low tilt shape to the waveform.
Figure 6 illustrates the defibrillation system 10' according to the second embodiment of the present invention.
Rather than two capacitors connected in parallel, a single high capacitance bipolar capacitor C3 is used. Preferably, the capacitance of capacitor C3 is about 640 microFarads and need be charged to 360 volts, as opposed to conventional devices which use 125 microFarad aluminum electrolytic capacitors charged to 780 volts. A capacitor in the range of 200-1600 microFarads is appropriate, depending on application requirements, but preferably at least 200 microFarads. The lower voltage needed to charge the capacitor C3 simplifies the design of the pulse generator circuitry. This allows switches to be used with lower voltage and current ratings. Switches with lower ratings are more readily available, and reliability is improved if peak voltages and currents are reduced.
The operation of the system 10' with capacitor C3 is the same as for system 10. However, the capacitor C3 may provide an 208~38~
~__itional functional advantage. Specifically, because capacitor C3 is a low leakage bipolar capacitor, it can sustain charge longer than conventional smaller capacitors, without substantial leakage.
Therefore, the capacitor C3 may be charged prior to a tachyarrhythmia detection and discharged immediately upon detection of a tachyarrhythmia, thus speeding up the response time of an implantable defibrillator (or cardioverter). For example, the capacitor C3 may retain charge for more than one day prior to a discharge, i.e. that less than ten percent of the original stored energy drains in one day. Additionally, by virtue of its large capacitance, multiple shocks can be delivered without recharging the capacitor.
The biphasic waveform according to the present invention appears to have several advantages over known defibrillation/
cardioversion waveforms. By lengthening waveform duration, peak currents and voltages are decreased. Consequently, tissue damage caused by the peak voltage of the first phase can be minimized, and post-shock sensing of the heart is thereby improved. Because peak voltage and current are lower with the longer duration waveform, the output circuitry can be simplified and made more robust. These benefits are achieved with little or no in~rease in energy requirements.
The biphasic waveform according to the present invention can be generated using constant tilt or constant duration methods.
One could also use constant duration for one phase and constant tilt for the other. In addition, system impedance could be ~_ermined and, based on that measurement, a constant duration or constant tilt system be automatically selected.
The foregoing description is intended by way of example only and is not intended to limit the present invention in any way except as set forth in the following claims.
DEFTRRTT.T.~TOR WAVEFORM GT'NT'T~TOR
FOR GT~'NT~'T~TING WAVEFORM OF LONG DURATION
BACKGROUND OF THE INVENTION
The present invention relates to cardiac defibrillation, and more particularly to a defibrillation system including a pulse generator which generates a long duration defibrillation waveform.
When used hereinafter, the term "defibrillation" is meant to include high energy defibrillation and lower energy cardioversion.
Present defibrillation devices generate and deliver a truncated exponential waveform with a duration less than 12 msec, or some variation thereof. According to conventional wisdom, the use of defibrillation waveforms with durations 15-20 msec or longer would be counter-indicated for defibrillation. In particular, it has been the assumption by experts in the field that the strength-duration relationship of a biphasic waveform are the same as for a monophasic waveform. That is, it is the general consensus that increasing waveform duration prohibitively increases the necessary energy requirements.
:"
_ In the last five years, there have been several reports of human and animal studies showing that some biphasic waveforms are more efficacious than monophasic waveforms. See Jones et al., "Increasing Fibrillation Duration Enhances Relative Asymmetric Biphasic Versus Monophasic Defibrillator Waveform Efficacy", Circulation and Respiration, 376-384, Vol. 67 (1990); Bardy et al, "A Prospective Randomized Evaluation of Bipolar Versus Monopolar Waveform Pulses on Defibrillation Efficacy in Humans", Journal of the American College of Cardiology, 728-733, Vol. 14 (1989); and Winkle et al., "Improved Low Energy Defibrillation Efficacy in Man With the Use of a Biphasic Truncated Exponential Waveform", American Heart Journal, 122-127, Vol. 117 (1989). These articles describe a ratio of energy requirements of a biphasic waveform as compared to the monophasic waveform that is less than 1Ø None of these articles indicate that ratio may be dependent on waveform duration.
The present generation of defibrillators have, to a large extent, been designed using strength-duration data determined with monophasic waveforms. When monophasic truncated exponential waveforms are used, defibrillation waveforms with long pulse durations (>10 msec) have no advantages over shorter duration waveforms.
Therefore, manufacturers of implantable defibrillator devices have used output capacitors with a capacitance of 60 to 150 microFarads and waveform durations less than 15 msec, and typically less than 10 msec. Waveform durations have been maintained - - -bstantially the same as manufacturers have changed their defibrillator designs to produce biphasic defibrillation shocks.
Recent patents further demonstrate that state-of-the-art defibrillation waveforms have durations shorter than 15 msec. See, for example, U.S. Patent No. 4,548,203 to Tacker, Jr. et al., 4,953,551 to Mehra et al., and 4,821,723 to Baker et al.
It is known that the pulse duration has a major impact on the strength requirements for stimulating tissue. Since most theories of defibrillation involve stimulation of refractory tissue, one would expect the strength-duration relationship for defibrillation to be at least qualitatively similar to that of pacing. This has been born out by studies by Wassale et al. and Konig et al. and described in their respective articles "Bipolar Catheter Defibrillation in Dogs Using Trapezoidal Waveforms of Various Tilts", Journal of Electrocardiology, 359-366, Vol. 13 (1980), hereinafter "Wassale et al."; and "Amplitude-Duration Relationship for Direct Ventricular Defibrillation with Rectangular Current Pulses", Medical Biological Enqineerinq, 388-395, Vol. 13 (1975), hereinafter "Konig et al.". The overall shape of the strength-duration curves for defibrillation with both monophasic truncated exponential and rectangular waveforms are similar to those determined for pacing. However, the pulse durations that minimize energy delivery requirements are lower for pacing (0.5 msec) as described by Irnich in the article "The Chronaxie Time and Its Practical Importance", PACE, 292-301, Vol. 3 (1980), 208838~
-einafter "Irnich", than for defibrillation (4 msec) as described -by Wassale et al.
Defibrillation with monophasic waveforms appears to follow a hyperbolic strength-duration relationship, as does pacing.
Defibrillation strength requirements have been measured for rectangular waveforms of different durations (1, 2, 5, 10, 20, 30 and 40 msec). See Konig et al. A good fit was found between their current amplitude data and a hyperbolic strength-duration curve with a chronaxie (a duration that gives minimum energy) at about 4 msec. In the aforementioned article by Wassale et al., strength-duration curves for monophasic truncated exponential waveforms were determined for several different tilts. Current requirements for these trapezoidal waveforms also increased as shock duration decreased, but shock energy was minimized at 2 to 4 msec, depending on the tilt. Both studies show a strength-duration relationship for defibrillation that is similar to that seen in pacing.
However, it was found by Irnich that the chronaxie for pacing with rectangular waveforms is about 0.5 msec, while the chronaxie for defibrillation with monophasic waveforms is about 4 msec.
In an article by Chapman et al. entitled "Strength-Duration Curves of Fixed Pulse Width Variable Tilt Truncated Exponential Waveforms for Nonthoracotomy Internal Defibrillation in Dogs", PACE, 1045-1050, Vol. 11 (1988). The curve of delivered energy requirements versus pulse width for delivered energy is described for single-capacitor monophasic wa~eforms (exponential with fixed time constants). Energy requirements increased 2088~84 ~otonically by only 50% as duration was increased from 2.5 to 15 msec, then increased dramatically for pulses of 20 msec durations.
Energy requirements for the 20 msec pulse were 1.5 times that of the energy required for 15 msec pulses.
Feeser et al., in their article entitled "Strength-Duration and Probability of Success Curves for Defibrillation With Biphasic Waveforms", Circulation, 2128-2141, Vol. 82 (1990), showed that for at least some biphasic waveforms, extending waveform durations to more than 15 msec dramatically increases energy requirements. However, unlike our experiments described below, tilt was not held constant in any of their experiments. In the study described by Feeser et al., trailing edges for long waveforms were sometimes very low. MacDaniel et al., in their article entitled "Optimal Biphasic Duration for Canine Defibrillation with a 'Single Capacitor' Waveform and a Non-Thoracotomy Electrode System", Annual Conference of IEEE EMBS, 1990, Volume 12, pages 636-637, showed that, for monophasic pulses of long duration, low trailing voltages are disadvantageous.
It has previously been shown that for fixed-duration shocks, the effectiveness of the truncated biphasic waveforms is critically dependent on the exact shape of the waveform. MacDaniel et al. and Feeser et al. have shown that for single capacitor waveforms, defibrillation shock efficacy varies as the ratio of the durations of the first and second phases is changed. Biphasic waveforms with first or second phases of short duration are actually less efficacious than monophasic pulses.
The strength-duration curves we found for the type of biphasic waveforms used are very different from those previously determined for truncated monophasic waveforms. The strength-duration relationship for energy requirements with biphasic truncated exponential waveforms were relatively flat and may greatly improve implantable defibrillator designs. Specifically, we discovered that defibrillation with long biphasic defibrillation pulses (20 msec) requires significantly lower peak voltages, with almost no increase in energy requirements.
Animal studies involving the present invention studied the effect of waveform duration on defibrillation efficacy of a biphasic truncated exponential waveform in six pigs. In each pig, defibrillation success curves were determined for waveform durations of 3, 5, 7, 10, 15 and 30 msec. The waveform shape chosen was of the "single capacitor" type with the trailing edge of the first pulse equal in magnitude to the leading edge of the second. The first pulse terminated at 40%, and the second pulse at 20% of the initial voltage of the first pulse, with the time constants of each phase being equal.
The effect of waveform duration on defibrillation efficacy of a monophasic truncated exponential waveform was determined in an additional six pigs. Waveform durations were the same as with the biphasic waveform, except the longest duration tested was 24 msec rather than 30 msec. The monophasic waveform terminated at 40% of the initial voltage.
All shocking electrodes were placed by fluoroscopy. One llF 3.4 cm long coil was positioned in the right ventricle and another coil of the same dimension was located in the high right atrium. A subcutaneous wire array electrode (100 cm2) was positioned such that the image of the right ventricular shocking coil and the subcutaneous electrode coincided in a lateral view.
Thoracic X-ray films were made to verify correct placement of both shocking catheters and the subcutaneous electrode.
Fibrillation was allowed to run for 15 seconds after induction with a 9 volt DC signal between an endocardial sensing lead and an indifferent electrode. Then defibrillation was attempted with a defibrillator designed for research using a shock of the selected waveform duration. Rescue monophasic transthoracic defibrillation shocks were given with an external defibrillator (about 100 J) through an electrode pad on the right thorax and the subcutaneous electrode on the left. Only the initial shock of each fibrillation episode was used to evaluate defibrillation efficacy.
The energy requirements for defibrillation were measured for the six waveform durations with the shocks being delivered according to an interleaved up/down protocol (described below). A total of 15 shocks were delivered by this protocol for each of the six durations (a total of 90 shocks). Data from these shocks were used to determine probability-of-success curves for each waveform duration.
208~384 TABLE I
Peak Current Am~litudes of First Shocks For Waveforms of Indicated Duration 8iphasic Monophasic 5Duration Peak I (Amp) Duration Peak I (AmP) 3 22.5 3 22.5 13.3 5 12.0 7 10.0 7 12.0 7.8 10 12.0 7.0 15 12.0 6.3 24 12.0 Table I above shows the peak delivered current for the initial shock given for each of the six waveform durations. It should be noted that the current levels for first shocks were different for the monophasic and biphasic waveforms. For all succeeding shocks, the peak current and success of the immediately preceding shock with that waveform duration determined the peak current selected. If the prior shock at that waveform duration failed, then the peak current was increased by one step; for a successful shock, the peak current was decreased by one step.
Initial current step sizes were 20%; at the first reversal, the step size was decreased to 10%.
The interleaving protocol was carried out as follows.
The six durations were arranged in random order, then the first test shocks for each duration were delivered in that random order.
The order was again randomized, and the second test shock for each duration were delivered according to the new order. That process was continued with 15 separate randomizations of order used, one for each of the 15 shoc~s delivered for each shock duration. This methodology ensured that, for example, the tenth shock given at one 208838~
~ ation always preceded the eleventh shock given at another duration.
Pulse width and initial current were selected by the protocol described above. These values, plus the measured energy and voltage were recorded for each shock. Two minutes separated each fibrillation-defibrillation episode, unless more time was required for the animal to return to basal conditions as indicated by surface or endocardial ECG's, or blood pressure measurements.
For each pulse duration, two parameter probability-of-success curves (mid-point and width) were determined for delivered energy, peak voltage and current. To produce the sigmoid defibrillation success curves, modified error functions were fitted to the data of conversion success or failure for each measured value using the maximum likelihood method. For each pulse duration, the energies, voltages and currents at which the percent probabilities for defibrillation success equaled 50~ (E50, V50 and I50) and 80% (E80, V~0 and I80) were determined from the success curves.
As shown in Figure 1, for the biphasic waveform, it was found that shock duration had no statistically significant effect on energy requirements over the range of 3 to 15 msec. Energy requirements were increased about 25% for shock durations of 30 msec. For the monophasic waveform as shown in Figure 1, defibrillation energy requirements increased monotonically as shock durations were increased from 3 to 24 msec. The E50 for shocks 3 20~83~4 _, msec long was 11.6+3.1 joules compared to 36.8+9.7 joules for shocks 24 msec long.
For the biphasic waveforms, it was found that current and voltage requirements declined monotonically with increases in waveform duration as shown in Figure 2.
Peak current and voltage requirements were 2.5 times higher for waveform durations of 3 msec than for durations of 30 msec. For the monophasic waveforms, current and voltage requirements declined significantly as shock durations were increased from 3 to 10 msec as shown in Figure 3. There was no significant further decreases as the durations were set at 15 and 24 msec, respectively.
It is therefore an object of the present invention to provide a novel system for generating a defibrillation waveform including a defibrillator and an electrode structure.
SUMMARY OF THE INVENTION
According to one aspect of the present invention there is provided a system for generating a defibrillation waveform including a defibrillator and an electrode structure, the system comprislng:
a single capacitor having a capacitance of at least 200 microFarads;
means for charging said capacitor to a maximum voltage of less than 400 volts;
A
switch means for connecting said capacitor to said electrode structure; and switch control means for controlling said switch means to connect said capacitor to said electrode structure for discharge via said electrode structure in a first polarity for a first phase of a biphasic waveform, and to connect said capacitor to said electrode structure in a polarity opposite said first polarity for a second phase of said biphasic waveform:
the first phase having duration equal to or greater than said second phase, the total duration of the first and second phases being at least 15 milliseconds, a trailing edge voltage of said first phase being greater than fifty percent of a leading edge voltage of the first phase and the biphasic waveform having a fixed tilt so as to produce a fixed low tilt biphasic waveform.
Preferably, a single large value, low leakage bipolar capacitor is used. It is also preferred that the defibrillation shock waveform has an overall duration of 15 msec to 80 msec. From our animal experiments, we expect to substantially reduce current and voltage requirements with such waveforms in external and implantable defibrillation systems.
There are several advantages to a defibrillation waveform requiring lower peak voltages.
First, tissue stunning, heart block and heart dysfunction are minimized. Second, the pulse generator output circuitry may be simplified and have greater reliability.
.~
20~3~4 BRIEF DESCRIPTION OF THE DRAWINGS
The above and other objects and advantages will become more readily apparent when reference is made to the following description taken in conjunction with the accompanying drawings in which:
Figure 1 is a graph illustrating energy versus duration relationships for monophasic and biphasic waveforms determined from animal studies.
Figure 2 is a graph illustrating voltage and current versus duration relationships for biphasic waveforms determined from animal studies.
Figure 3 is a graph illustrating voltage and current versus duration relationships for monophasic waveforms determined from animal studies.
Figure 4 is a schematic diagram illustrating the implantable defibrillation system according to a first embodiment of the present invention.
Figure 5 is a diagram of a biphasic waveform generated by the pulse generator of the implantable defibrillation/cardioversion system according to the present invention.
Figure 6 is a schematic diagram illustrating the implantable defibrillation system according to a second embodiment of the present invention.
.
' 12a DETAILED DESCRIPTION OF THE DRAWINGS
Figure 1 illustrates the strength-duration relationships for delivered energy of a constant-tilt biphasic waveform and of a constant-tilt monophasic truncated exponential waveform. The data from this graph were obtained from two series of pig experiments, the details of which are described above. Energy requirements were s~nificantly lower for the biphasic waveform at all durations tested above 5 msec. It is quite evident from this figure that the relative benefit of the biphasic waveform is very dependent on waveform duration. For durations of 3 or 5 msec, the energy advantage for the biphasic waveform is small. However, for the durations used according to the present invention, the biphasic energy requirements are several-fold lower than the monophasic waveform. It should also be noted that the strength-duration curve for energy of the biphasic waveform is quite flat over waveform durations of 3 to 30 msec.
Figures 2 and 3 illustrate the strength-duration relationships for peak voltage and current requirements for constant-tilt biphasic and monophasic waveforms, respectively. The data from these graphs were obtained from two series of pig experiments, the details of which are described above. Figure 2 shows that for the constant-tilt biphasic waveform, peak voltage and current requirements decrease monotonically with increases in duration for pulse durations of 3 to 30 msec. A comparison of Figure 1 and 2 shows that peak voltage and current can be decreased substantially, with almost no penalty in increased energy requirements, if a biphasic waveform with long duration (greater than 15 msec) is used. In contrast, for the monophasic waveform, no significant changes in peak voltage and current requirements were observed as waveform duration was increased from 10 to 24 msec (Figure 3).
208838~
- Figure 4 illustrates the defibrillation system according to the first embodiment, which is generally shown at 10. The system 10 includes sensing electrodes 12 and circuitry for amplifying and analyzing the cardiac rhythm, in the form of an ECG
amplifier 14 and a cardiac analyzer 16. The cardiac analyzer 16 determines when the heart is in a condition requiring a defibrillation (or cardioversion) shock and issues a control signal, causing the shock to be delivered to the heart via electrodes 18 and 20. The system 10 (as well as system 10' to be described hereinafter) represents an implantable or external defibrillation system. In an implantable system, electrodes 18 and 20 may be implanted on or about the heart, one may be subcutaneous, and each may comprise one or more electrode, though only one is shown for each. In the case of an external defibrillator, the circuitry may be disposed external to the body of a patient but connect with implantable electrodes. Alternatively, the external unit may connect with at least two cutaneous electrodes placed on the body.
The thrust of the present invention lies in the pulse generator circuitry, which is generally shown at 22. The pulse generator circuitry includes capacitors Cl and C2 connected in parallel. The capacitors Cl and C2 are charged by the voltage supply Vc via a DC-DC converter 21, and are connected to the electrodes 18 and 20 via lead lines 24 and 26. A plurality of switches S1-S4 are provided between t~e capacitors Cl and C2 and the lead lines 24 and 26. Preferably, capacitors Cl and C2 are 250 Il roFarads each, but may be in the range of 100-800 microFarads.
-The overall capacitance therefore is the sum of the capacitance of capacitors Cl and C2, which in the preferred embodiment is 200 to 1600 microFarads, but at least 200 microFarads or greater.
A switch controller 30 is provided to control the switches S1-S5, for controlling the charge and discharge of the capacitors Cl and C2. In general, the switch controller 30 controls the switches so that a biphasic waveform is generated from the discharge of the capacitors Cl and C2.
With reference to Figures 4 and 5, the method by which the biphasic waveform 40 is generated will be described. The capacitors Cl and C2 are charged via the voltage supply Vc, by closing the switch S5. This may be controlled by the switch controller 30, or the cardiac analyzer 16. Once charged, the switch controller generates phase 1 of the waveform by closing switches S1 and S4, and opening switches S2 and S3. This connects the capacitors Cl and C2 with positive polarity to lead lines 24 and 26. The discharge waveform for phase 1 will slowly decay from a leading edge voltage VLl to a trailing edge voltage VTl. The decay from VLl to VTl will be slow because the time constant for the circuit will be large, due to the sum of the capacitances of capacitors C1 and C2.
For the second phase of the waveform, the switch controller 30 opens switches Sl and S4 and closes switches S2 and S3, thereby connecting capacitors Cl and C2 to lead lines 24 and 26 with a polarity opposite to that of phase 1. Similar to phase 1, 208~384 ~_ discharge waveform for phase 2 decays at a rather slow rate from the leading edge voltage VL2 to the trailing edge voltage VT2.
The magnitude of the leading edge voltage of phase 2, VL2, is equal to the magnitude of the trailing edge voltage VT1 of phase 1.
Preferably, the duration of the waveform shown in Figure 5 is 20-40 msec, with the first phase consuming 60 percent of the total duration. In addition, the trailing edge voltage VT1 of the first phase is preferably larger than fifty percent of the leading edge voltage VL1, giving a low tilt shape to the waveform.
Figure 6 illustrates the defibrillation system 10' according to the second embodiment of the present invention.
Rather than two capacitors connected in parallel, a single high capacitance bipolar capacitor C3 is used. Preferably, the capacitance of capacitor C3 is about 640 microFarads and need be charged to 360 volts, as opposed to conventional devices which use 125 microFarad aluminum electrolytic capacitors charged to 780 volts. A capacitor in the range of 200-1600 microFarads is appropriate, depending on application requirements, but preferably at least 200 microFarads. The lower voltage needed to charge the capacitor C3 simplifies the design of the pulse generator circuitry. This allows switches to be used with lower voltage and current ratings. Switches with lower ratings are more readily available, and reliability is improved if peak voltages and currents are reduced.
The operation of the system 10' with capacitor C3 is the same as for system 10. However, the capacitor C3 may provide an 208~38~
~__itional functional advantage. Specifically, because capacitor C3 is a low leakage bipolar capacitor, it can sustain charge longer than conventional smaller capacitors, without substantial leakage.
Therefore, the capacitor C3 may be charged prior to a tachyarrhythmia detection and discharged immediately upon detection of a tachyarrhythmia, thus speeding up the response time of an implantable defibrillator (or cardioverter). For example, the capacitor C3 may retain charge for more than one day prior to a discharge, i.e. that less than ten percent of the original stored energy drains in one day. Additionally, by virtue of its large capacitance, multiple shocks can be delivered without recharging the capacitor.
The biphasic waveform according to the present invention appears to have several advantages over known defibrillation/
cardioversion waveforms. By lengthening waveform duration, peak currents and voltages are decreased. Consequently, tissue damage caused by the peak voltage of the first phase can be minimized, and post-shock sensing of the heart is thereby improved. Because peak voltage and current are lower with the longer duration waveform, the output circuitry can be simplified and made more robust. These benefits are achieved with little or no in~rease in energy requirements.
The biphasic waveform according to the present invention can be generated using constant tilt or constant duration methods.
One could also use constant duration for one phase and constant tilt for the other. In addition, system impedance could be ~_ermined and, based on that measurement, a constant duration or constant tilt system be automatically selected.
The foregoing description is intended by way of example only and is not intended to limit the present invention in any way except as set forth in the following claims.
Claims (8)
1. A system for generating a defibrillation waveform including a defibrillator and an electrode structure, the system comprising:
a single capacitor having a capacitance of at least 200 microFarads;
means for charging said capacitor to a maximum voltage of less than 400 volts;
switch means for connecting said capacitor to said electrode structure; and switch control means for controlling said switch means to connect said capacitor to said electrode structure for discharge via said electrode structure in a first polarity for a first phase of a biphasic waveform, and to connect said capacitor to said electrode structure in a polarity opposite said first polarity for a second phase of said biphasic waveform:
the first phase having duration equal to or greater than said second phase, the total duration of the first and second phases being at least 15 milliseconds, a trailing edge voltage of said first phase being greater than fifty percent of a leading edge voltage of the first phase and the biphasic waveform having a fixed tilt so as to produce a fixed low tilt biphasic waveform.
a single capacitor having a capacitance of at least 200 microFarads;
means for charging said capacitor to a maximum voltage of less than 400 volts;
switch means for connecting said capacitor to said electrode structure; and switch control means for controlling said switch means to connect said capacitor to said electrode structure for discharge via said electrode structure in a first polarity for a first phase of a biphasic waveform, and to connect said capacitor to said electrode structure in a polarity opposite said first polarity for a second phase of said biphasic waveform:
the first phase having duration equal to or greater than said second phase, the total duration of the first and second phases being at least 15 milliseconds, a trailing edge voltage of said first phase being greater than fifty percent of a leading edge voltage of the first phase and the biphasic waveform having a fixed tilt so as to produce a fixed low tilt biphasic waveform.
2. The system of claim 1, wherein the capacitor has a capacitance of 200-1600 microFarads.
3. The system of claim 1, wherein said first and second phases have a total duration of 15-80 msec.
4. The system of claim 1, wherein said system includes an implantable housing for containing said capacitor, said charging means, said switch means, and said switch control means.
5. The system of claim 4, wherein the electrode structure comprises one or more electrodes adapted to be implanted on or about the heart and one or more electrodes adapted to be implanted subcutaneously.
6. The system of claim 1, wherein the system is adapted to be partially implantable, the defibrillator being adapted to be an external defibrillator, and wherein the electrode structure comprises at least two electrodes adapted to be implanted on or about the heart.
7. The system of claim 1, wherein the system is adapted to be partially implantable, the defibrillator being adapted to be an external defibrillator, and wherein the electrode structure comprises one or more electrodes adapted to be implanted on or about the heart and one or more electrodes adapted to be implanted subcutaneously.
8. The system of claim 1, wherein the system is adapted to be partially implantable, the defibrillator being adapted to be an external defibrillator, and wherein the electrode structure comprises at least two cutaneous electrodes adapted to be placed on the body.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82721592A | 1992-01-30 | 1992-01-30 | |
| US07/827,215 | 1992-01-30 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2088384A1 CA2088384A1 (en) | 1993-07-31 |
| CA2088384C true CA2088384C (en) | 1998-09-01 |
Family
ID=25248605
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002088384A Expired - Fee Related CA2088384C (en) | 1992-01-30 | 1993-01-29 | Defibrillator waveform generator for generating waveform of long duration |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US5634938A (en) |
| EP (1) | EP0553864B1 (en) |
| JP (1) | JPH05337204A (en) |
| AT (1) | ATE185980T1 (en) |
| AU (1) | AU3209393A (en) |
| CA (1) | CA2088384C (en) |
| DE (1) | DE69326850T2 (en) |
Families Citing this family (197)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5468254A (en) * | 1993-07-26 | 1995-11-21 | Cardiac Pacemakers, Inc. | Method and apparatus for defibrillation using a multiphasic truncated exponential waveform |
| US5601612A (en) * | 1993-08-06 | 1997-02-11 | Heartstream, Inc. | Method for applying a multiphasic waveform |
| FR2710848B1 (en) * | 1993-10-08 | 1995-12-01 | Ela Medical Sa | Implantable defibrillator with optically isolated shock generator. |
| FR2711064B1 (en) * | 1993-10-15 | 1995-12-01 | Ela Medical Sa | Implantable defibrillator / pacemaker with multiphase shock generator. |
| FR2711065B1 (en) * | 1993-10-15 | 1995-12-01 | Ela Medical Sa | Circuit for the reconstruction of a shock energy storage capacitor in an implantable defibrillator. |
| US5507785A (en) * | 1994-12-21 | 1996-04-16 | Intermedics, Inc. | Rate responsive cardiac pacemaker with biphasic impedance sensing and method |
| US5904697A (en) * | 1995-02-24 | 1999-05-18 | Heartport, Inc. | Devices and methods for performing a vascular anastomosis |
| US5813999A (en) * | 1995-12-21 | 1998-09-29 | Incontrol, Inc. | Implantable atrial defibrillator providing reduced cardioversion discomfort |
| US5891172A (en) * | 1996-06-27 | 1999-04-06 | Survivalink Corporation | High voltage phase selector switch for external defibrillators |
| EP1535645A1 (en) * | 1996-12-18 | 2005-06-01 | Zmd Corporation | Electrotherapy current waveform |
| US6963773B2 (en) | 1997-03-05 | 2005-11-08 | Medtronic Physio-Control Manufacturing Corp. | H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator using single SCR and IGBT switches in an integrated package |
| US6175765B1 (en) | 1997-03-05 | 2001-01-16 | Medtronic Physio-Control Manufacturing Corp. | H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator |
| US5873893A (en) * | 1997-03-05 | 1999-02-23 | Physio-Control Corporation | Method and apparatus for verifying the integrity of an output circuit before and during application of a defibrillation pulse |
| US5824017A (en) * | 1997-03-05 | 1998-10-20 | Physio-Control Corporation | H-bridge circuit for generating a high-energy biphasic waveform in an external defibrillator |
| US6556863B1 (en) * | 1998-10-02 | 2003-04-29 | Cardiac Pacemakers, Inc. | High-energy capacitors for implantable defibrillators |
| US6208895B1 (en) | 1998-10-13 | 2001-03-27 | Physio-Control Manufacturing Corporation | Circuit for performing external pacing and biphasic defibrillation |
| US6212429B1 (en) | 1998-10-13 | 2001-04-03 | Physio-Control Manufacturing Corporation | Method and apparatus for converting a monophasic defibrillator to a biphasic defibrillator |
| US6241751B1 (en) | 1999-04-22 | 2001-06-05 | Agilent Technologies, Inc. | Defibrillator with impedance-compensated energy delivery |
| US6684102B1 (en) * | 2000-11-03 | 2004-01-27 | Cardiac Pacemakers, Inc. | Implantable heart monitors having capacitors with endcap headers |
| US7456077B2 (en) * | 2000-11-03 | 2008-11-25 | Cardiac Pacemakers, Inc. | Method for interconnecting anodes and cathodes in a flat capacitor |
| US6522525B1 (en) * | 2000-11-03 | 2003-02-18 | Cardiac Pacemakers, Inc. | Implantable heart monitors having flat capacitors with curved profiles |
| US6509588B1 (en) | 2000-11-03 | 2003-01-21 | Cardiac Pacemakers, Inc. | Method for interconnecting anodes and cathodes in a flat capacitor |
| US6699265B1 (en) * | 2000-11-03 | 2004-03-02 | Cardiac Pacemakers, Inc. | Flat capacitor for an implantable medical device |
| US7107099B1 (en) | 2000-11-03 | 2006-09-12 | Cardiac Pacemakers, Inc. | Capacitor having a feedthrough assembly with a coupling member |
| US6687118B1 (en) * | 2000-11-03 | 2004-02-03 | Cardiac Pacemakers, Inc. | Flat capacitor having staked foils and edge-connected connection members |
| US7355841B1 (en) * | 2000-11-03 | 2008-04-08 | Cardiac Pacemakers, Inc. | Configurations and methods for making capacitor connections |
| US20030125771A1 (en) * | 2001-08-01 | 2003-07-03 | Medical Research Laboratories, Inc. | Multiphasic defibrillator utilizing controlled energy pulses |
| WO2003020362A2 (en) * | 2001-08-31 | 2003-03-13 | Access Cardiosystems, Inc. | Automated external defibrillator (aed) system |
| US6965796B2 (en) | 2002-03-11 | 2005-11-15 | Medtronic Physio-Control Manufacturing Corp. | Method and apparatus for self-test of defibrillation and pacing circuits including a patient isolation switch |
| US7096062B2 (en) | 2002-03-11 | 2006-08-22 | Medtronic Physio-Control Manufacturing Corp. | Method for self-test of defibrillation and pacing circuits including a patient isolation switch |
| US6968230B2 (en) | 2002-06-26 | 2005-11-22 | Medtronic Physio-Control Manufacturing Corp | H-bridge circuit for generating a high-energy biphasic and external pacing waveform in an external defibrillator |
| US7189204B2 (en) | 2002-12-04 | 2007-03-13 | Cardiac Pacemakers, Inc. | Sleep detection using an adjustable threshold |
| US7392081B2 (en) * | 2003-02-28 | 2008-06-24 | Cardiac Pacemakers, Inc. | Subcutaneous cardiac stimulator employing post-shock transthoracic asystole prevention pacing |
| US7349742B2 (en) * | 2003-04-11 | 2008-03-25 | Cardiac Pacemakers, Inc. | Expandable fixation elements for subcutaneous electrodes |
| US7493175B2 (en) * | 2003-04-11 | 2009-02-17 | Cardiac Pacemakers, Inc. | Subcutaneous lead with tined fixation |
| US7499758B2 (en) * | 2003-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Helical fixation elements for subcutaneous electrodes |
| US7702399B2 (en) * | 2003-04-11 | 2010-04-20 | Cardiac Pacemakers, Inc. | Subcutaneous electrode and lead with phoresis based pharmacological agent delivery |
| US20040204734A1 (en) * | 2003-04-11 | 2004-10-14 | Wagner Darrell Orvin | Tunneling tool with subcutaneous transdermal illumination |
| US20040220626A1 (en) * | 2003-04-11 | 2004-11-04 | Wagner Darrell Orvin | Distributed subcutaneous defibrillation system |
| US20040230230A1 (en) * | 2003-04-11 | 2004-11-18 | Lindstrom Curtis Charles | Methods and systems involving subcutaneous electrode positioning relative to a heart |
| US20040204735A1 (en) * | 2003-04-11 | 2004-10-14 | Shiroff Jason Alan | Subcutaneous dissection tool incorporating pharmacological agent delivery |
| US7302294B2 (en) * | 2003-04-11 | 2007-11-27 | Cardiac Pacemakers, Inc. | Subcutaneous cardiac sensing and stimulation system employing blood sensor |
| US20050004615A1 (en) * | 2003-04-11 | 2005-01-06 | Sanders Richard S. | Reconfigurable implantable cardiac monitoring and therapy delivery device |
| US7236819B2 (en) | 2003-04-11 | 2007-06-26 | Cardiac Pacemakers, Inc. | Separation of a subcutaneous cardiac signal from a plurality of composite signals |
| US7529592B2 (en) * | 2003-04-11 | 2009-05-05 | Cardiac Pacemakers, Inc. | Subcutaneous electrode and lead with temporary pharmacological agents |
| US7389138B2 (en) * | 2003-04-11 | 2008-06-17 | Cardiac Pacemakers, Inc. | Electrode placement determination for subcutaneous cardiac monitoring and therapy |
| US7566318B2 (en) * | 2003-04-11 | 2009-07-28 | Cardiac Pacemakers, Inc. | Ultrasonic subcutaneous dissection tool incorporating fluid delivery |
| US7555335B2 (en) | 2003-04-11 | 2009-06-30 | Cardiac Pacemakers, Inc. | Biopotential signal source separation using source impedances |
| US7865233B2 (en) | 2003-04-11 | 2011-01-04 | Cardiac Pacemakers, Inc. | Subcutaneous cardiac signal discrimination employing non-electrophysiologic signal |
| US7570997B2 (en) | 2003-04-11 | 2009-08-04 | Cardiac Pacemakers, Inc. | Subcutaneous cardiac rhythm management with asystole prevention therapy |
| US20040220628A1 (en) * | 2003-04-11 | 2004-11-04 | Wagner Darrell Orvin | Subcutaneous defibrillation timing correlated with induced skeletal muscle contraction |
| US7499750B2 (en) | 2003-04-11 | 2009-03-03 | Cardiac Pacemakers, Inc. | Noise canceling cardiac electrodes |
| US20040230272A1 (en) * | 2003-04-11 | 2004-11-18 | Cates Adam W. | Subcutaneous lead with temporary pharmacological agents |
| US7218966B2 (en) * | 2003-04-11 | 2007-05-15 | Cardiac Pacemakers, Inc. | Multi-parameter arrhythmia discrimination |
| US7117035B2 (en) | 2003-04-11 | 2006-10-03 | Cardiac Pacemakers, Inc. | Subcutaneous cardiac stimulation system with patient activity sensing |
| US7047071B2 (en) | 2003-04-11 | 2006-05-16 | Cardiac Pacemakers, Inc. | Patient stratification for implantable subcutaneous cardiac monitoring and therapy |
| US7979122B2 (en) * | 2003-04-11 | 2011-07-12 | Cardiac Pacemakers, Inc. | Implantable sudden cardiac death prevention device with reduced programmable feature set |
| US8116868B2 (en) | 2003-04-11 | 2012-02-14 | Cardiac Pacemakers, Inc. | Implantable device with cardiac event audio playback |
| US20040215240A1 (en) * | 2003-04-11 | 2004-10-28 | Lovett Eric G. | Reconfigurable subcutaneous cardiac device |
| US20050107838A1 (en) * | 2003-09-18 | 2005-05-19 | Lovett Eric G. | Subcutaneous cardiac rhythm management with disordered breathing detection and treatment |
| US7396333B2 (en) | 2003-08-18 | 2008-07-08 | Cardiac Pacemakers, Inc. | Prediction of disordered breathing |
| US8002553B2 (en) | 2003-08-18 | 2011-08-23 | Cardiac Pacemakers, Inc. | Sleep quality data collection and evaluation |
| US8606356B2 (en) | 2003-09-18 | 2013-12-10 | Cardiac Pacemakers, Inc. | Autonomic arousal detection system and method |
| US7887493B2 (en) | 2003-09-18 | 2011-02-15 | Cardiac Pacemakers, Inc. | Implantable device employing movement sensing for detecting sleep-related disorders |
| EP2008581B1 (en) | 2003-08-18 | 2011-08-17 | Cardiac Pacemakers, Inc. | Patient monitoring, diagnosis, and/or therapy systems and methods |
| US20060247693A1 (en) | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
| US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
| US8521284B2 (en) | 2003-12-12 | 2013-08-27 | Cardiac Pacemakers, Inc. | Cardiac response classification using multisite sensing and pacing |
| US20050215884A1 (en) * | 2004-02-27 | 2005-09-29 | Greicius Michael D | Evaluation of Alzheimer's disease using an independent component analysis of an individual's resting-state functional MRI |
| US7480531B1 (en) | 2004-05-26 | 2009-01-20 | Pacesetter, Inc. | System and method for reducing pain associated with cardioversion shocks generated by implantable cardiac stimulation devices |
| US7706866B2 (en) | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
| US7224575B2 (en) * | 2004-07-16 | 2007-05-29 | Cardiac Pacemakers, Inc. | Method and apparatus for high voltage aluminum capacitor design |
| US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
| US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
| US7509170B2 (en) | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
| US7805185B2 (en) * | 2005-05-09 | 2010-09-28 | Cardiac Pacemakers, In. | Posture monitoring using cardiac activation sequences |
| US7890159B2 (en) * | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
| US7647108B2 (en) * | 2004-09-30 | 2010-01-12 | Cardiac Pacemakers, Inc. | Methods and systems for selection of cardiac pacing electrode configurations |
| US7457664B2 (en) | 2005-05-09 | 2008-11-25 | Cardiac Pacemakers, Inc. | Closed loop cardiac resynchronization therapy using cardiac activation sequence information |
| US7418293B2 (en) * | 2004-11-09 | 2008-08-26 | Cardiac Pacemakers, Inc. | Multiple pulse defibrillation for subcutaneous implantable cardiac devices |
| US8818504B2 (en) | 2004-12-16 | 2014-08-26 | Cardiac Pacemakers Inc | Leadless cardiac stimulation device employing distributed logic |
| US7996072B2 (en) * | 2004-12-21 | 2011-08-09 | Cardiac Pacemakers, Inc. | Positionally adaptable implantable cardiac device |
| US7680534B2 (en) | 2005-02-28 | 2010-03-16 | Cardiac Pacemakers, Inc. | Implantable cardiac device with dyspnea measurement |
| US7392086B2 (en) | 2005-04-26 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable cardiac device and method for reduced phrenic nerve stimulation |
| US20070049975A1 (en) * | 2005-09-01 | 2007-03-01 | Cates Adam W | Active can with dedicated defibrillation and sensing electrodes |
| US7775983B2 (en) * | 2005-09-16 | 2010-08-17 | Cardiac Pacemakers, Inc. | Rapid shallow breathing detection for use in congestive heart failure status determination |
| US20070118180A1 (en) | 2005-11-18 | 2007-05-24 | Quan Ni | Cardiac resynchronization therapy for improved hemodynamics based on disordered breathing detection |
| US7766840B2 (en) * | 2005-12-01 | 2010-08-03 | Cardiac Pacemakers, Inc. | Method and system for heart failure status evaluation based on a disordered breathing index |
| US20070135847A1 (en) * | 2005-12-12 | 2007-06-14 | Kenknight Bruce H | Subcutaneous defibrillation system and method using same |
| US7662105B2 (en) | 2005-12-14 | 2010-02-16 | Cardiac Pacemakers, Inc. | Systems and methods for determining respiration metrics |
| US7761158B2 (en) * | 2005-12-20 | 2010-07-20 | Cardiac Pacemakers, Inc. | Detection of heart failure decompensation based on cumulative changes in sensor signals |
| US7640065B1 (en) | 2006-03-17 | 2009-12-29 | Pacesetter, Inc. | Cardiac constraint/therapeutic stimulation device |
| US7819816B2 (en) * | 2006-03-29 | 2010-10-26 | Cardiac Pacemakers, Inc. | Periodic disordered breathing detection |
| US8527048B2 (en) | 2006-06-29 | 2013-09-03 | Cardiac Pacemakers, Inc. | Local and non-local sensing for cardiac pacing |
| US8170662B2 (en) * | 2006-08-03 | 2012-05-01 | Cardiac Pacemakers, Inc. | Method and apparatus for charging partitioned capacitors |
| US8761875B2 (en) * | 2006-08-03 | 2014-06-24 | Cardiac Pacemakers, Inc. | Method and apparatus for selectable energy storage partitioned capacitor |
| US8154853B2 (en) * | 2006-08-03 | 2012-04-10 | Cardiac Pacemakers, Inc. | Method and apparatus for partitioned capacitor |
| US8209013B2 (en) | 2006-09-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Therapeutic electrical stimulation that avoids undesirable activation |
| US8948867B2 (en) | 2006-09-14 | 2015-02-03 | Cardiac Pacemakers, Inc. | Capture detection with cross chamber backup pacing |
| US7856265B2 (en) * | 2007-02-22 | 2010-12-21 | Cardiac Pacemakers, Inc. | High voltage capacitor route with integrated failure point |
| US8052611B2 (en) | 2007-03-14 | 2011-11-08 | Cardiac Pacemakers, Inc. | Method and apparatus for management of heart failure hospitalization |
| US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
| US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
| JP2011505964A (en) | 2007-12-12 | 2011-03-03 | カーディアック ペースメイカーズ， インコーポレイテッド | Implantable medical device with Hall sensor |
| WO2009094335A1 (en) * | 2008-01-22 | 2009-07-30 | Cardiac Pacemakers, Inc. | Respiration as a trigger for therapy optimization |
| EP2254661B1 (en) | 2008-02-14 | 2015-10-07 | Cardiac Pacemakers, Inc. | Apparatus for phrenic stimulation detection |
| EP2349467B1 (en) * | 2008-10-06 | 2017-08-23 | Cardiac Pacemakers, Inc. | Dynamic cardiac resynchronization therapy by tracking intrinsic conduction |
| US20110009760A1 (en) * | 2009-07-10 | 2011-01-13 | Yi Zhang | Hospital Readmission Alert for Heart Failure Patients |
| US9129749B2 (en) | 2009-12-18 | 2015-09-08 | Cardiac Pacemakers, Inc. | Sintered electrodes to store energy in an implantable medical device |
| US8619408B2 (en) * | 2009-12-18 | 2013-12-31 | Cardiac Pacemakers, Inc. | Sintered capacitor electrode including a folded connection |
| US9269498B2 (en) | 2009-12-18 | 2016-02-23 | Cardiac Pacemakers, Inc. | Sintered capacitor electrode including multiple thicknesses |
| US8725252B2 (en) | 2009-12-18 | 2014-05-13 | Cardiac Pacemakers, Inc. | Electric energy storage device electrode including an overcurrent protector |
| US8873220B2 (en) * | 2009-12-18 | 2014-10-28 | Cardiac Pacemakers, Inc. | Systems and methods to connect sintered aluminum electrodes of an energy storage device |
| US9123470B2 (en) | 2009-12-18 | 2015-09-01 | Cardiac Pacemakers, Inc. | Implantable energy storage device including a connection post to connect multiple electrodes |
| US8848341B2 (en) | 2010-06-24 | 2014-09-30 | Cardiac Pacemakers, Inc. | Electronic component mounted on a capacitor electrode |
| WO2015020979A1 (en) | 2013-08-05 | 2015-02-12 | Cardiac Pacemakers, Inc. | System and method for detecting worsening of heart failure based on rapid shallow breathing index |
| WO2015106015A1 (en) | 2014-01-10 | 2015-07-16 | Cardiac Pacemakers, Inc. | Systems and methods for detecting cardiac arrhythmias |
| CN106102830B (en) | 2014-01-10 | 2019-07-16 | 心脏起搏器股份公司 | For improving the method and system of the communication between medical device |
| US9782601B2 (en) | 2014-04-15 | 2017-10-10 | Cardiac Pacemakers, Inc. | Pacing device with autonomous anti-tachycardia pacing |
| WO2016033197A2 (en) | 2014-08-28 | 2016-03-03 | Cardiac Pacemakers, Inc. | Medical device with triggered blanking period |
| JP6510660B2 (en) | 2015-02-06 | 2019-05-08 | カーディアック ペースメイカーズ， インコーポレイテッド | System and method for treating cardiac arrhythmias |
| ES2713231T3 (en) | 2015-02-06 | 2019-05-20 | Cardiac Pacemakers Inc | Systems for the safe supply of electrical stimulation therapy |
| US10046167B2 (en) | 2015-02-09 | 2018-08-14 | Cardiac Pacemakers, Inc. | Implantable medical device with radiopaque ID tag |
| US11285326B2 (en) | 2015-03-04 | 2022-03-29 | Cardiac Pacemakers, Inc. | Systems and methods for treating cardiac arrhythmias |
| WO2016149262A1 (en) | 2015-03-18 | 2016-09-22 | Cardiac Pacemakers, Inc. | Communications in a medical device system with link quality assessment |
| US10050700B2 (en) | 2015-03-18 | 2018-08-14 | Cardiac Pacemakers, Inc. | Communications in a medical device system with temporal optimization |
| US10357159B2 (en) | 2015-08-20 | 2019-07-23 | Cardiac Pacemakers, Inc | Systems and methods for communication between medical devices |
| EP3337558A1 (en) | 2015-08-20 | 2018-06-27 | Cardiac Pacemakers, Inc. | Systems and methods for communication between medical devices |
| US9968787B2 (en) | 2015-08-27 | 2018-05-15 | Cardiac Pacemakers, Inc. | Spatial configuration of a motion sensor in an implantable medical device |
| US9956414B2 (en) | 2015-08-27 | 2018-05-01 | Cardiac Pacemakers, Inc. | Temporal configuration of a motion sensor in an implantable medical device |
| US10226631B2 (en) | 2015-08-28 | 2019-03-12 | Cardiac Pacemakers, Inc. | Systems and methods for infarct detection |
| CN108136189B (en) | 2015-08-28 | 2021-10-15 | 心脏起搏器股份公司 | System for behavioral response signal detection and therapy delivery |
| WO2017040115A1 (en) | 2015-08-28 | 2017-03-09 | Cardiac Pacemakers, Inc. | System for detecting tamponade |
| WO2017044389A1 (en) | 2015-09-11 | 2017-03-16 | Cardiac Pacemakers, Inc. | Arrhythmia detection and confirmation |
| EP3359251B1 (en) | 2015-10-08 | 2019-08-07 | Cardiac Pacemakers, Inc. | Adjusting pacing rates in an implantable medical device |
| EP3389775B1 (en) | 2015-12-17 | 2019-09-25 | Cardiac Pacemakers, Inc. | Conducted communication in a medical device system |
| US10905886B2 (en) | 2015-12-28 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device for deployment across the atrioventricular septum |
| WO2017127548A1 (en) | 2016-01-19 | 2017-07-27 | Cardiac Pacemakers, Inc. | Devices for wirelessly recharging a rechargeable battery of an implantable medical device |
| WO2017136548A1 (en) | 2016-02-04 | 2017-08-10 | Cardiac Pacemakers, Inc. | Delivery system with force sensor for leadless cardiac device |
| WO2017173275A1 (en) | 2016-03-31 | 2017-10-05 | Cardiac Pacemakers, Inc. | Implantable medical device with rechargeable battery |
| US10328272B2 (en) | 2016-05-10 | 2019-06-25 | Cardiac Pacemakers, Inc. | Retrievability for implantable medical devices |
| US10668294B2 (en) | 2016-05-10 | 2020-06-02 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker configured for over the wire delivery |
| US10512784B2 (en) | 2016-06-27 | 2019-12-24 | Cardiac Pacemakers, Inc. | Cardiac therapy system using subcutaneously sensed P-waves for resynchronization pacing management |
| WO2018009569A1 (en) | 2016-07-06 | 2018-01-11 | Cardiac Pacemakers, Inc. | Method and system for determining an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
| US10426962B2 (en) | 2016-07-07 | 2019-10-01 | Cardiac Pacemakers, Inc. | Leadless pacemaker using pressure measurements for pacing capture verification |
| WO2018017226A1 (en) | 2016-07-20 | 2018-01-25 | Cardiac Pacemakers, Inc. | System for utilizing an atrial contraction timing fiducial in a leadless cardiac pacemaker system |
| WO2018035343A1 (en) | 2016-08-19 | 2018-02-22 | Cardiac Pacemakers, Inc. | Trans septal implantable medical device |
| CN109640809B (en) | 2016-08-24 | 2021-08-17 | 心脏起搏器股份公司 | Integrated multi-device cardiac resynchronization therapy using P-wave to pacing timing |
| EP3503970B1 (en) | 2016-08-24 | 2023-01-04 | Cardiac Pacemakers, Inc. | Cardiac resynchronization using fusion promotion for timing management |
| US10905889B2 (en) | 2016-09-21 | 2021-02-02 | Cardiac Pacemakers, Inc. | Leadless stimulation device with a housing that houses internal components of the leadless stimulation device and functions as the battery case and a terminal of an internal battery |
| US10758737B2 (en) | 2016-09-21 | 2020-09-01 | Cardiac Pacemakers, Inc. | Using sensor data from an intracardially implanted medical device to influence operation of an extracardially implantable cardioverter |
| WO2018057626A1 (en) | 2016-09-21 | 2018-03-29 | Cardiac Pacemakers, Inc. | Implantable cardiac monitor |
| US10413733B2 (en) | 2016-10-27 | 2019-09-17 | Cardiac Pacemakers, Inc. | Implantable medical device with gyroscope |
| US10765871B2 (en) | 2016-10-27 | 2020-09-08 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
| US10463305B2 (en) | 2016-10-27 | 2019-11-05 | Cardiac Pacemakers, Inc. | Multi-device cardiac resynchronization therapy with timing enhancements |
| US10561330B2 (en) | 2016-10-27 | 2020-02-18 | Cardiac Pacemakers, Inc. | Implantable medical device having a sense channel with performance adjustment |
| EP3532159B1 (en) | 2016-10-27 | 2021-12-22 | Cardiac Pacemakers, Inc. | Implantable medical device delivery system with integrated sensor |
| WO2018081237A1 (en) | 2016-10-27 | 2018-05-03 | Cardiac Pacemakers, Inc. | Use of a separate device in managing the pace pulse energy of a cardiac pacemaker |
| JP6843235B2 (en) | 2016-10-31 | 2021-03-17 | カーディアック ペースメイカーズ， インコーポレイテッド | Systems and methods for activity level pacing |
| CN109890456B (en) | 2016-10-31 | 2023-06-13 | 心脏起搏器股份公司 | System for activity level pacing |
| WO2018089311A1 (en) | 2016-11-08 | 2018-05-17 | Cardiac Pacemakers, Inc | Implantable medical device for atrial deployment |
| US10632313B2 (en) | 2016-11-09 | 2020-04-28 | Cardiac Pacemakers, Inc. | Systems, devices, and methods for setting cardiac pacing pulse parameters for a cardiac pacing device |
| US10881869B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Wireless re-charge of an implantable medical device |
| US10894163B2 (en) | 2016-11-21 | 2021-01-19 | Cardiac Pacemakers, Inc. | LCP based predictive timing for cardiac resynchronization |
| CN109996585B (en) | 2016-11-21 | 2023-06-13 | 心脏起搏器股份公司 | Implantable medical device with magnetically permeable housing and induction coil disposed around the housing |
| US10639486B2 (en) | 2016-11-21 | 2020-05-05 | Cardiac Pacemakers, Inc. | Implantable medical device with recharge coil |
| US10881863B2 (en) | 2016-11-21 | 2021-01-05 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with multimode communication |
| US11207532B2 (en) | 2017-01-04 | 2021-12-28 | Cardiac Pacemakers, Inc. | Dynamic sensing updates using postural input in a multiple device cardiac rhythm management system |
| EP3573708B1 (en) | 2017-01-26 | 2021-03-10 | Cardiac Pacemakers, Inc. | Leadless implantable device with detachable fixation |
| JP7000438B2 (en) | 2017-01-26 | 2022-01-19 | カーディアック ペースメイカーズ， インコーポレイテッド | Human device communication with redundant message transmission |
| CN110234392B (en) | 2017-01-26 | 2023-08-11 | 心脏起搏器股份公司 | Leadless device with overmolded component |
| AU2018248361B2 (en) | 2017-04-03 | 2020-08-27 | Cardiac Pacemakers, Inc. | Cardiac pacemaker with pacing pulse energy adjustment based on sensed heart rate |
| US10905872B2 (en) | 2017-04-03 | 2021-02-02 | Cardiac Pacemakers, Inc. | Implantable medical device with a movable electrode biased toward an extended position |
| US10946207B2 (en) | 2017-05-27 | 2021-03-16 | West Affum Holdings Corp. | Defibrillation waveforms for a wearable cardiac defibrillator |
| US11065459B2 (en) | 2017-08-18 | 2021-07-20 | Cardiac Pacemakers, Inc. | Implantable medical device with pressure sensor |
| US10918875B2 (en) | 2017-08-18 | 2021-02-16 | Cardiac Pacemakers, Inc. | Implantable medical device with a flux concentrator and a receiving coil disposed about the flux concentrator |
| CN111107899B (en) | 2017-09-20 | 2024-04-02 | 心脏起搏器股份公司 | Implantable medical device with multiple modes of operation |
| US11185703B2 (en) | 2017-11-07 | 2021-11-30 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker for bundle of his pacing |
| WO2019108830A1 (en) | 2017-12-01 | 2019-06-06 | Cardiac Pacemakers, Inc. | Leadless cardiac pacemaker with reversionary behavior |
| EP3717059A1 (en) | 2017-12-01 | 2020-10-07 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials within a search window from a ventricularly implanted leadless cardiac pacemaker |
| CN111417433A (en) | 2017-12-01 | 2020-07-14 | 心脏起搏器股份公司 | Method and system for detecting atrial contraction timing reference during ventricular filling from a ventricular implanted leadless cardiac pacemaker |
| WO2019108482A1 (en) | 2017-12-01 | 2019-06-06 | Cardiac Pacemakers, Inc. | Methods and systems for detecting atrial contraction timing fiducials and determining a cardiac interval from a ventricularly implanted leadless cardiac pacemaker |
| US11529523B2 (en) | 2018-01-04 | 2022-12-20 | Cardiac Pacemakers, Inc. | Handheld bridge device for providing a communication bridge between an implanted medical device and a smartphone |
| US10874861B2 (en) | 2018-01-04 | 2020-12-29 | Cardiac Pacemakers, Inc. | Dual chamber pacing without beat-to-beat communication |
| CN111886046A (en) | 2018-03-23 | 2020-11-03 | 美敦力公司 | AV-synchronized VFA cardiac therapy |
| US11058880B2 (en) | 2018-03-23 | 2021-07-13 | Medtronic, Inc. | VFA cardiac therapy for tachycardia |
| CN111902187A (en) | 2018-03-23 | 2020-11-06 | 美敦力公司 | VFA cardiac resynchronization therapy |
| CN112770807A (en) | 2018-09-26 | 2021-05-07 | 美敦力公司 | Capture in atrial-to-ventricular cardiac therapy |
| US11679265B2 (en) | 2019-02-14 | 2023-06-20 | Medtronic, Inc. | Lead-in-lead systems and methods for cardiac therapy |
| EP3789077B1 (en) * | 2019-02-26 | 2022-08-31 | iCorNet Laboratory Co., Ltd. | Cardiac support net and implantable defibrillator |
| US11697025B2 (en) | 2019-03-29 | 2023-07-11 | Medtronic, Inc. | Cardiac conduction system capture |
| US11213676B2 (en) | 2019-04-01 | 2022-01-04 | Medtronic, Inc. | Delivery systems for VfA cardiac therapy |
| US11712188B2 (en) | 2019-05-07 | 2023-08-01 | Medtronic, Inc. | Posterior left bundle branch engagement |
| US11305127B2 (en) | 2019-08-26 | 2022-04-19 | Medtronic Inc. | VfA delivery and implant region detection |
| US11813466B2 (en) | 2020-01-27 | 2023-11-14 | Medtronic, Inc. | Atrioventricular nodal stimulation |
| US11911168B2 (en) | 2020-04-03 | 2024-02-27 | Medtronic, Inc. | Cardiac conduction system therapy benefit determination |
| US11813464B2 (en) | 2020-07-31 | 2023-11-14 | Medtronic, Inc. | Cardiac conduction system evaluation |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR85383E (en) * | 1961-12-30 | 1965-07-30 | Serdal Electron Med | Lightweight capacitor array, especially for cardiac defibrillation |
| FR1317369A (en) * | 1961-12-30 | 1963-02-08 | Electronique Medicale Serdal L | Lightweight capacitor array, especially for cardiac defibrillation |
| US4375817A (en) * | 1979-07-19 | 1983-03-08 | Medtronic, Inc. | Implantable cardioverter |
| US4548203A (en) * | 1982-06-01 | 1985-10-22 | Purdue Research Foundation | Sequential-pulse, multiple pathway defibrillation method |
| US4637797A (en) * | 1985-01-11 | 1987-01-20 | Access Learning Technology Corporation | Software training system |
| JPS6283625A (en) * | 1985-10-08 | 1987-04-17 | Shimadzu Corp | Optical power meter |
| US4800883A (en) * | 1986-04-02 | 1989-01-31 | Intermedics, Inc. | Apparatus for generating multiphasic defibrillation pulse waveform |
| US4953551A (en) * | 1987-01-14 | 1990-09-04 | Medtronic, Inc. | Method of defibrillating a heart |
| US4821723A (en) * | 1987-02-27 | 1989-04-18 | Intermedics Inc. | Biphasic waveforms for defibrillation |
| US4850357A (en) * | 1988-01-12 | 1989-07-25 | Cardiac Pacemakers, Inc. | Biphasic pulse generator for an implantable defibrillator |
| DE68925218T2 (en) * | 1988-01-19 | 1996-07-25 | Telectronics Nv | Method and apparatus for the application of asymmetric, two-phase, cut off exponential counter shocks |
| US4810742A (en) * | 1988-02-01 | 1989-03-07 | Occidental Chemical Corporation | UV stable, impact resistant, flame retarded ABS composition containing aliphatic resin |
| US5199429A (en) * | 1991-05-23 | 1993-04-06 | Angemed, Inc. | Implantable defibrillator system employing capacitor switching networks |
| US5411525A (en) * | 1992-01-30 | 1995-05-02 | Cardiac Pacemakers, Inc. | Dual capacitor biphasic defibrillator waveform generator employing selective connection of capacitors for each phase |
-
1993
- 1993-01-29 EP EP93101426A patent/EP0553864B1/en not_active Revoked
- 1993-01-29 AU AU32093/93A patent/AU3209393A/en not_active Abandoned
- 1993-01-29 AT AT93101426T patent/ATE185980T1/en not_active IP Right Cessation
- 1993-01-29 CA CA002088384A patent/CA2088384C/en not_active Expired - Fee Related
- 1993-01-29 DE DE69326850T patent/DE69326850T2/en not_active Expired - Fee Related
- 1993-02-01 JP JP5014832A patent/JPH05337204A/en active Pending
-
1995
- 1995-10-25 US US08/547,845 patent/US5634938A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| AU3209393A (en) | 1993-08-05 |
| EP0553864B1 (en) | 1999-10-27 |
| ATE185980T1 (en) | 1999-11-15 |
| US5634938A (en) | 1997-06-03 |
| EP0553864A2 (en) | 1993-08-04 |
| EP0553864A3 (en) | 1995-01-18 |
| DE69326850D1 (en) | 1999-12-02 |
| JPH05337204A (en) | 1993-12-21 |
| CA2088384A1 (en) | 1993-07-31 |
| DE69326850T2 (en) | 2000-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2088384C (en) | Defibrillator waveform generator for generating waveform of long duration | |
| US6047211A (en) | Dual capacitor biphasic defibrillator waveform generator employing selective connection of capacitors for each phase | |
| US5489293A (en) | Method and apparatus for treating cardiac tachyarrhythmia | |
| US5324309A (en) | Overlapping pulse cardioversion or defibrillation | |
| US5522853A (en) | Method and apparatus for progressive recruitment of cardiac fibrillation | |
| US7065403B1 (en) | System and method for measuring lead impedance in an implantable stimulation device employing pulse-train waveforms | |
| US4953551A (en) | Method of defibrillating a heart | |
| US7769445B2 (en) | Implantable cardioverter-defibrillator with post-shock reset | |
| US7751881B2 (en) | Acoustically-powered wireless defibrillator | |
| US5447518A (en) | Method and apparatus for phase related cardiac defibrillation | |
| US6006131A (en) | Dual current pathway atrial defibrillation apparatus | |
| US5431687A (en) | Impedance timed defibrillation system | |
| US6484056B2 (en) | System and method of generating a high efficiency biphasic defibrillation waveform for use in an implantable cardioverter/defibrillator (ICD) | |
| US20050165451A1 (en) | Method and apparatus for cardiac shock therapy | |
| US5718718A (en) | Method and apparatus for polarity reversal of consecutive defibrillation countershocks having back biasing precharge pulses | |
| EP1027104A1 (en) | Dual shock atrial defibrillation apparatus | |
| US5360435A (en) | Multiple pulse cardioversion or defibrillation | |
| EP0975390B1 (en) | Implantable triphasic waveform defibrillator | |
| EP0770410B1 (en) | An implantable atrial defibrillator having cardioverting output voltage limiting for simulating larger storage capacitors | |
| US5741303A (en) | Electrode back-charging pre-treatment system for an implantable cardioverter defibrillator | |
| US5813999A (en) | Implantable atrial defibrillator providing reduced cardioversion discomfort | |
| EP0547878B1 (en) | Defibrillation system with a small capacitor | |
| US7522958B2 (en) | Methods and systems for reducing discomfort from cardiac defibrillation shocks | |
| Block et al. | Biphasic defibrillation using a single capacitor with large capacitance: reduction of peak voltages and ICD device size | |
| Poole et al. | A Prospective Randomized Comparison in Humans of 90‐μF and 120‐μF Biphasic Pulse Defibrillation Using a Unipolar Defibrillation System |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |